3E Bioventures Capital
VC
INVESTOR TYPE
Active
STATUS
6
PROFESSIONALS
39
INVESTMENTS
24
PORTFOLIO
9
EXITS
Description
3E Bioventures Capital is a healthcare focused venture capital firm based in Beijing, China. The firm seeks to make investments in the drug, device, diagnostics, healthcare information technology and medical services sectors.
Website
Investor Status
Actively Seeking New Investments
Year Founded
2015
Primary Investor Type
Venture Capital
Primary Office
- Suite 701, Tower C, Tsinghua Science Park
- Number 1 Zhongguancun East Road
- Beijing, Haidian 100084
- China
+86 010 0000 0000
3E Bioventures Capital Investments (39)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Ansun Biopharma | 05-Sep-2019 | Later Stage VC | 000.00 | Biotechnology | Generating Revenue | 00000 000 00.0 |
| 000000 00000000 | 05-Aug-2019 | 00000 00000 | 00.000 | Other Healthcare Technology Systems | Generating Revenue | |
| 00000 | 25-Sep-2018 | 00000 00000 | 000.00 | Diagnostic Equipment | Generating Revenue | 00000000 0000 00.0 |
| 000000-000 | 18-Sep-2018 | 00000 00000 | 0000 | Biotechnology | Pre-Clinical Trials | |
| 0000000 | 14-Aug-2018 | 00000 00000 | 0000 | Other Devices and Supplies | Generating Revenue | 00000 000 00.0 |
| 00000000 | 08-Aug-2018 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 2 | 00000 000 00.0 |
| 00000 000000000 | 14-May-2018 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | 00000 000 00.0 |
| 000000 0000000 | 02-May-2018 | 00000 00000 | 0000 | Biotechnology | Startup | 00000 000 00.0 |
| Biocytogen | 10-Apr-2018 | Later Stage VC | 0000 | Biotechnology | Generating Revenue | |
| Twist Bioscience | 02-Apr-2018 | Later Stage VC | 00000 | Biotechnology | Generating Revenue/Not Profitable |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore 3E Bioventures Capital’s full profile, request a free trial.
3E Bioventures Capital Exits (9)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Twist Bioscience | 31-Oct-2018 | IPO | 0000 | Completed |
|
| 0000000 | 02-Nov-2016 | 000 | Completed |
|
|
| 00000000 000000000 | 06-Jul-2016 | 000000000000000000 | Completed |
|
|
| 000000000 | 06-Jan-2016 | 000 | Completed |
|
|
| 0000000000 | 01-Jan-2013 | 0000000000 | Completed |
|
|
| 000000 00000 | 000000000 00000000 | Completed |
|
||
| 000000000 | 000000000 00000000 | Completed |
|
||
| Micropoint Bioscience | Secondary Transaction - Private | Completed |
|
||
| Shenogen | Secondary Transaction - Private | Completed |
|
3E Bioventures Capital Team (8)
You’re viewing 5 of 8 team members. Get the full list »3E Bioventures Capital Co-Investors (86)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| Cowin Capital | 3 | ||
| ShangBay Capital | 0 | 0 | |
| Bay City Capital | 0 | 0 | |
| Korea Investment Partners | 0 | 0 | |
| Northern Light Venture Capital | 0 | 0 |